283 related articles for article (PubMed ID: 7820300)
21. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.
Izawa T; Obara T; Tanno S; Mizukami Y; Yanagawa N; Kohgo Y
Cancer; 2001 Oct; 92(7):1807-17. PubMed ID: 11745253
[TBL] [Abstract][Full Text] [Related]
22. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.
Tsukahara M; Nagai H; Kamiakito T; Kawata H; Takayashiki N; Saito K; Tanaka A
Pathol Int; 2005 Feb; 55(2):63-9. PubMed ID: 15693851
[TBL] [Abstract][Full Text] [Related]
23. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.
Nakamura A; Horinouchi M; Goto M; Nagata K; Sakoda K; Takao S; Imai K; Kim YS; Sato E; Yonezawa S
J Pathol; 2002 Jun; 197(2):201-10. PubMed ID: 12015744
[TBL] [Abstract][Full Text] [Related]
24. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.
Yoshizawa K; Nagai H; Sakurai S; Hironaka M; Morinaga S; Saitoh K; Fukayama M
Virchows Arch; 2002 Nov; 441(5):437-43. PubMed ID: 12447672
[TBL] [Abstract][Full Text] [Related]
25. Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreas.
Sugiyama M; Atomi Y
Am J Gastroenterol; 1999 Feb; 94(2):470-3. PubMed ID: 10022648
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
27. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas.
Kondo H; Sugano K; Fukayama N; Hosokawa K; Ohkura H; Ohtsu A; Mukai K; Yoshida S
Cancer; 1997 Mar; 79(5):900-5. PubMed ID: 9041151
[TBL] [Abstract][Full Text] [Related]
28. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
Mueller J; Gansauge S; Mattfeldt T
Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
[TBL] [Abstract][Full Text] [Related]
29. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases.
Yamaguchi K; Chijiiwa K; Noshiro H; Torata N; Kinoshita M; Tanaka M
Hepatogastroenterology; 1999; 46(28):2575-81. PubMed ID: 10522044
[TBL] [Abstract][Full Text] [Related]
30. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters.
Sugio K; Gazdar AF; Albores-Saavedra J; Kokkinakis DM
Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas.
Niijima M; Yamaguchi T; Ishihara T; Hara T; Kato K; Kondo F; Saisho H
Cancer; 2002 Mar; 94(5):1565-73. PubMed ID: 11920515
[TBL] [Abstract][Full Text] [Related]
32. Expression of integrins in intraductal papillary-mucinous tumors of the pancreas as an indicator of malignancy.
Sawai H; Okada Y; Tanaka M; Funahashi H; Hayakawa T; Manabe T
Pancreas; 2004 Jan; 28(1):20-4. PubMed ID: 14707725
[TBL] [Abstract][Full Text] [Related]
33. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.
Adsay NV; Merati K; Basturk O; Iacobuzio-Donahue C; Levi E; Cheng JD; Sarkar FH; Hruban RH; Klimstra DS
Am J Surg Pathol; 2004 Jul; 28(7):839-48. PubMed ID: 15223952
[TBL] [Abstract][Full Text] [Related]
34. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic analysis of k-ras, p53, and ERBB-2 gene alterations in pulmonary adenocarcinoma.
Visscher DW; Yadrandji S; Tabaczka P; Kraut M; Sarkar FH
Diagn Mol Pathol; 1997 Feb; 6(1):64-9. PubMed ID: 9028739
[TBL] [Abstract][Full Text] [Related]
36. Surgical management of intraductal papillary mucinous tumor of the pancreas.
Doi R; Fujimoto K; Wada M; Imamura M
Surgery; 2002 Jul; 132(1):80-5. PubMed ID: 12110799
[TBL] [Abstract][Full Text] [Related]
37. Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy.
Lévy P; Jouannaud V; O'Toole D; Couvelard A; Vullierme MP; Palazzo L; Aubert A; Ponsot P; Sauvanet A; Maire F; Hentic O; Hammel P; Ruszniewski P
Clin Gastroenterol Hepatol; 2006 Apr; 4(4):460-8. PubMed ID: 16616351
[TBL] [Abstract][Full Text] [Related]
38. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms. A single malignant clinicopathologic entity.
Rivera JA; Fernández-del Castillo C; Pins M; Compton CC; Lewandrowski KB; Rattner DW; Warshaw AL
Ann Surg; 1997 Jun; 225(6):637-44; discussion 644-6. PubMed ID: 9230804
[TBL] [Abstract][Full Text] [Related]
40. Expression of oncogene products, anti-oncogene products and oncofetal antigens in intraductal papillary-mucinous neoplasm of the pancreas.
Terada T; Ohta T; Nakanuma Y
Histopathology; 1996 Oct; 29(4):355-61. PubMed ID: 8910043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
